Works matching AU Xue, Jianxin

Results: 58
    1
    2
    3
    4

    Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.

    Published in:
    Oncology Letters, 2018, v. 15, n. 4, p. 5671, doi. 10.3892/ol.2018.8064
    By:
    • Hu, Binbin;
    • Zhou, Xiaojuan;
    • Liu, Yongmei;
    • Li, Qian;
    • Xiang, Mengmeng;
    • Zou, Bingwen;
    • Peng, Feng;
    • Huang, Meijuan;
    • Gong, Youling;
    • Zhu, Jiang;
    • Wang, Yongsheng;
    • Ren, Li;
    • Xu, Yong;
    • Zhang, Yan;
    • Li, Yanying;
    • Yu, Min;
    • Xue, Jianxin;
    • Deng, Lei;
    • Wang, Jin;
    • Ding, Zhenyu
    Publication type:
    Article
    5
    6
    7
    8

    Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 10, p. 2589, doi. 10.1007/s00432-021-03831-z
    By:
    • Wei, Hao;
    • Zhou, Xiaojuan;
    • Yang, Hui;
    • Gong, Youling;
    • Wang, Jin;
    • Xu, Yong;
    • Zhou, Lin;
    • Xue, Jianxin;
    • Zou, Bingwen;
    • Zhang, Yan;
    • Zhu, Jiang;
    • Peng, Feng;
    • Huang, Meijuan;
    • Lu, You;
    • Liu, Yongmei
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    JMJD family proteins in cancer and inflammation.

    Published in:
    Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01145-1
    By:
    • Manni, Wang;
    • Jianxin, Xue;
    • Weiqi, Hong;
    • Siyuan, Chen;
    • Huashan, Shi
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 23, p. 8772, doi. 10.1002/cam4.3485
    By:
    • Zhang, Tingyou;
    • Zhang, Yu;
    • Zhou, Lin;
    • Deng, Shanshan;
    • Huang, Meijuan;
    • Liu, Yuncong;
    • Liu, Yongmei;
    • Gong, Youlin;
    • Zhu, Jiang;
    • Xue, Jianxin;
    • Bai, Yuju;
    • Ma, Hu;
    • Zhang, Yan;
    • Yu, Min;
    • Li, Yanying;
    • Wang, Yongsheng;
    • Zou, Bingwen;
    • Zhou, Xiaojuan;
    • Xiu, Weigang;
    • Na, Feifei
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40

    PD-1/PD-L1 Inhibitors in Cervical Cancer.

    Published in:
    Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00065
    By:
    • Liu, Yuncong;
    • Wu, Li;
    • Tong, Ruizhan;
    • Yang, Feiyue;
    • Yin, Limei;
    • Li, Mengqian;
    • You, Liting;
    • Xue, Jianxin;
    • Lu, You
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches.

    Published in:
    Strahlentherapie und Onkologie, 2021, v. 197, n. 12, p. 1072, doi. 10.1007/s00066-021-01783-4
    By:
    • Mei, Ting;
    • Xiu, Weigang;
    • Yang, Xuexi;
    • Tian, Xiaoman;
    • Yu, Yang;
    • Xu, Yong;
    • Zhou, Lin;
    • Zhou, Xiaojuan;
    • Liu, Yongmei;
    • Zou, Bingwen;
    • Xue, Jianxin;
    • Ao, Rui;
    • Lu, You;
    • Gong, Youling
    Publication type:
    Article
    50